Korio RTSM Powers Complex Personalized Medicine Oncology Trial

Traditional clinical trials often treat investigational products (IPs) as commodities distributed across sites, but personalized medicine requires a fundamental shift in logic. In a complex Phase 1 oncology study, the challenge involves managing custom-manufactured therapies that must reach a specific participant at a precise time and location. Because legacy systems often struggle to adapt to these emerging supply chain needs, sponsors require a hyper-integrated approach that bridges the communication gap between clinical operations and manufacturing.

This case study examines the successful "rescue" and migration of an active global trial. By establishing a reusable framework for data collection and operational procedures, sponsors can streamline the setup for subsequent trial phases and future precision medicine programs.